Site Logo

Download QR

Open Free Demat Account!

Join Our 9 Lakh Customers

+91
Headphone

Home

Mutual Funds

WhiteOak Capital Pharma and Healthcare Fund

Wh

WhiteOak Capital Pharma and Healthcare Fund

Sectoral-PharmaRank #3
Not Rated

NAV (2026-07-14)

16.22

AUM

₹792.84 Cr

Exp. Ratio: 2.88%

RISK LEVEL

Very High

Returns & Performance

1 Year17.72%4.89% vs cat avgRank #3
3 Year----
5 Year----
Since Launch21.97%--

Fund vs Category Average

1Y
17.72%+4.89%

Pros & Cons

Pros

Outperforms category avg on 1Y returns
No lock-in period
Top-5 ranked in category for 1Y (#3)
Overall top-10 rank in category (#3)

Cons

3Y returns below category average
Higher expense ratio (2.88%)
ISININF03VN01878
NAV₹16.22
NAV Date2026-07-14
AUM₹792.84 Cr
Expense Ratio2.88%
RiskVery High
RatingNot Rated / 5
Min SIP Amount₹100
Max SIP Amount₹999999999
Min Additional Inv.₹500
SIP AllowedYes
Plan TypeRegular
Plan OptionGrowth
Is NFONo
Fund House Incorp.2018-07-03

INVESTMENT OBJECTIVE

The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Exit Load1.00%
Stamp duty on investment0.005% (from July 1st, 2020)
Tax implicationsIf you redeem within one year, your returns will be taxed at 20%. For redemptions after one year, returns exceeding ₹1.25 lakh in a financial year will be taxed at 12.5%.

Trupti Agrawal

Ms. Agrawal has done B.Com and CA.

Prior to joining WhiteOak Capital Mutual Fund, she has worked with L&T Infrastructure Finance Co. Ltd. and Ernst & Young.

Top Holdings

Holdings data not available for this scheme